Can chemotherapy cause vision changes?

Translate to Spanish or other 102 languages!

 Although most changes usually stop after the treatment, some may last longer. Sudden vision changes need immediate medical attention. Image for illustration purposes
Although most changes usually stop after the treatment, some may last longer. Sudden vision changes need immediate medical attention. Image for illustration purposes
- Advertisement -

Chemotherapy can affect a person’s vision. Although most changes usually stop after the treatment, some may last longer. Sudden vision changes need immediate medical attention.

While most vision side effects are temporary, some can also be long term. Healthcare professionals can help people manage these changes to their vision.

This article discusses how chemotherapy affects vision, how long the side effects may last, and which chemotherapy drugs can affect vision. It also discusses how people can manage chemotherapy vision changes.

- Advertisement -

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/can-chemotherapy-affect-your-vision?slot_pos=article_3&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-14&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -